Implications of the 2023–2024 MPXV clade I outbreak in the Democratic Republic of Congo to global public health

Angel N. Desai; Marion Koopmans; Ashley Otter; Martin P. Grobusch; Pikka Jokelainen; Barry Atkinson; Flavia Cunha; Sofia R. Valdoleiros; Veronica G. Preda; Francesco Maria Fusco; Chantal P. Rovers; Gilbert Greub; Antonino Di Caro; Lone Simonsen; Francine Ntoumi; Eskild Petersen

doi:10.1016/j.cmi.2024.04.016

Implications of the 2023–2024 MPXV clade I outbreak in the Democratic Republic of Congo to global public health

Angel N. Desai, Marion Koopmans, Ashley Otter, Martin P. Grobusch, Pikka Jokelainen, Barry Atkinson, Flavia Cunha, Sofia R. Valdoleiros, Veronica G. Preda, Francesco Maria Fusco, Chantal P. Rovers, Gilbert Greub, Antonino Di Caro, Lone Simonsen, Francine Ntoumi, Eskild Petersen^*

^*Corresponding author for this work

Research output: Contribution to journal › Comment/debate › Research › peer-review

Abstract

Mpox, a zoonotic disease resulting from infection with monkeypox virus (MPXV), was previously considered endemic to Central and West Africa. However, an ongoing global outbreak of clade IIb (previously known as West African clade) MPXV, associated with human-to-human transmission primarily through sexual contact, has occurred since May 2022, with introduction of MPXV to regions and countries that had previously only reported sporadic imported cases [ 1, 2].

Original language	English
Journal	Clinical Microbiology and Infection
Volume	30
Issue number	9
Pages (from-to)	1092-1094
Number of pages	3
ISSN	1198-743X
DOIs	https://doi.org/10.1016/j.cmi.2024.04.016
Publication status	Published - Sept 2024

Bibliographical note

Funding Information:
MK and PJ are part of DURABLE consortium, co-funded under EU4Health programme under grant agreement 101102733. LS and EP acknowledge financial support for the PandemiX Center, from the Danish National Research Foundation (grant No. DNRF170).

Link to document

10.1016/j.cmi.2024.04.016

Cite this

Desai, A. N., Koopmans, M., Otter, A., Grobusch, M. P., Jokelainen, P., Atkinson, B., Cunha, F., Valdoleiros, S. R., Preda, V. G., Fusco, F. M., Rovers, C. P., Greub, G., Di Caro, A., Simonsen, L., Ntoumi, F., & Petersen, E. (2024). Implications of the 2023–2024 MPXV clade I outbreak in the Democratic Republic of Congo to global public health. Clinical Microbiology and Infection, 30(9), 1092-1094. https://doi.org/10.1016/j.cmi.2024.04.016

@article{858aa552dd29484089cadfbda570ec33,

title = "Implications of the 2023–2024 MPXV clade I outbreak in the Democratic Republic of Congo to global public health",

abstract = "Mpox, a zoonotic disease resulting from infection with monkeypox virus (MPXV), was previously considered endemic to Central and West Africa. However, an ongoing global outbreak of clade IIb (previously known as West African clade) MPXV, associated with human-to-human transmission primarily through sexual contact, has occurred since May 2022, with introduction of MPXV to regions and countries that had previously only reported sporadic imported cases [ 1, 2].",

author = "Desai, {Angel N.} and Marion Koopmans and Ashley Otter and Grobusch, {Martin P.} and Pikka Jokelainen and Barry Atkinson and Flavia Cunha and Valdoleiros, {Sofia R.} and Preda, {Veronica G.} and Fusco, {Francesco Maria} and Rovers, {Chantal P.} and Gilbert Greub and {Di Caro}, Antonino and Lone Simonsen and Francine Ntoumi and Eskild Petersen",

note = "Funding Information: MK and PJ are part of DURABLE consortium, co-funded under EU4Health programme under grant agreement 101102733. LS and EP acknowledge financial support for the PandemiX Center, from the Danish National Research Foundation (grant No. DNRF170).",

year = "2024",

month = sep,

doi = "10.1016/j.cmi.2024.04.016",

language = "English",

volume = "30",

pages = "1092--1094",

journal = "Clinical Microbiology and Infection",

issn = "1198-743X",

publisher = "Elsevier Ltd",

number = "9",

}

Desai, AN, Koopmans, M, Otter, A, Grobusch, MP, Jokelainen, P, Atkinson, B, Cunha, F, Valdoleiros, SR, Preda, VG, Fusco, FM, Rovers, CP, Greub, G, Di Caro, A, Simonsen, L, Ntoumi, F & Petersen, E 2024, 'Implications of the 2023–2024 MPXV clade I outbreak in the Democratic Republic of Congo to global public health', Clinical Microbiology and Infection, vol. 30, no. 9, pp. 1092-1094. https://doi.org/10.1016/j.cmi.2024.04.016

TY - JOUR

T1 - Implications of the 2023–2024 MPXV clade I outbreak in the Democratic Republic of Congo to global public health

AU - Desai, Angel N.

AU - Koopmans, Marion

AU - Otter, Ashley

AU - Grobusch, Martin P.

AU - Jokelainen, Pikka

AU - Atkinson, Barry

AU - Cunha, Flavia

AU - Valdoleiros, Sofia R.

AU - Preda, Veronica G.

AU - Fusco, Francesco Maria

AU - Rovers, Chantal P.

AU - Greub, Gilbert

AU - Di Caro, Antonino

AU - Simonsen, Lone

AU - Ntoumi, Francine

AU - Petersen, Eskild

N1 - Funding Information: MK and PJ are part of DURABLE consortium, co-funded under EU4Health programme under grant agreement 101102733. LS and EP acknowledge financial support for the PandemiX Center, from the Danish National Research Foundation (grant No. DNRF170).

PY - 2024/9

Y1 - 2024/9

N2 - Mpox, a zoonotic disease resulting from infection with monkeypox virus (MPXV), was previously considered endemic to Central and West Africa. However, an ongoing global outbreak of clade IIb (previously known as West African clade) MPXV, associated with human-to-human transmission primarily through sexual contact, has occurred since May 2022, with introduction of MPXV to regions and countries that had previously only reported sporadic imported cases [ 1, 2].

AB - Mpox, a zoonotic disease resulting from infection with monkeypox virus (MPXV), was previously considered endemic to Central and West Africa. However, an ongoing global outbreak of clade IIb (previously known as West African clade) MPXV, associated with human-to-human transmission primarily through sexual contact, has occurred since May 2022, with introduction of MPXV to regions and countries that had previously only reported sporadic imported cases [ 1, 2].

U2 - 10.1016/j.cmi.2024.04.016

DO - 10.1016/j.cmi.2024.04.016

M3 - Comment/debate

C2 - 38697394

AN - SCOPUS:85194051612

SN - 1198-743X

VL - 30

SP - 1092

EP - 1094

JO - Clinical Microbiology and Infection

JF - Clinical Microbiology and Infection

IS - 9

ER -